senkyunolide I/H

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 异苯并呋喃
• 英文名称: senkyunolide I/H
• 英文别名: 6,7-dihydroxyligustilide；senkyunolide I；3-butylidene-4,5,6,7-tetrahydro-6,7-dihydroxy-1(3H)-isobenzofuranone；3-Butylidene-6,7-dihydroxy-4,5,6,7-tetrahydro-2-benzofuran-1-one
• 化学式: C₁₂H₁₆O₄
• 分子量: 224.257
• InChiKey: DQNGMIQSXNGHOA-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.5
• 重原子数：
  16
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.58
• 拓扑面积：
  66.8
• 氢给体数：
  2
• 氢受体数：
  4

文献信息

• A MULTI-COMPONENT INJECTION
  申请人：TIANJIN CHASE SUN PHARMACEUTICAL CO., LTD.

  公开号：US20190269609A1

  公开（公告）日：2019-09-05

  The invention relates to the technical field of medicines, and particularly relates to a multi-component injection and preparation processes and applications thereof. In the present invention, the effective ingredients of safflower carthamus. Red Paeony Root, Ligusticum wallichii , radix salviae miltiorrhizae and Angelica sinensis are analyzed and a multi-component injection is prepared via the modern pharmaceutical preparation technology. The study proves that the multi-component injection of the invention has therapeutic effects on Sepsis.
• MULTI-COMPONENT INJECTION
  申请人：TIANJIN CHASE SUN PHARMACEUTICAL CO. LTD

  公开号：US20210346281A1

  公开（公告）日：2021-11-11

  The invention relates to the technical field of medicines, and particularly relates to a multi-component injection and preparation processes and applications thereof. In the present invention, the effective ingredients of safflower Carthamus, Red Paeony Root, Ligusticum wallichii , radix salvia miltiorrhizae and Angelica sinensis are analyzed and a multi-component injection is prepared via the modem pharmaceutical preparation technology. The study proves that the multi-component injection of the invention has therapeutic effects on Sepsis.